netFormulary NHS
Cambridgeshire and Peterborough
Formulary
 Search
 Results

Looking for Adalimumab found 19 matches

Formulary items 5 matches
   
Formulary BNF Category
  Restricted Drug  Adalimumab  (Amgevita,Humira, Imraldi)
(Dermatology, Injection)
Drugs affecting the immune response - 13.05.03
  Restricted Drug  Adalimumab  (Amgevita, Humira, Imraldi)
(Gastroenterology)
Cytokine inhibitors - 01.05.03
  Restricted Drug  Adalimumab  (Amgevita, Humira, Imraldi)
(Rheumatology - Injection SC)
Drugs affecting the immune response - 10.01.03
  Restricted Drug  Adalimumab  (Amgevita, Humira, Imraldi)
(opthalmology)
Immunosuppressants - 11.99.99.99
  Restricted Drug  Etanercept  (Enbrel, Benepali )
(Dermatology, Injection)
Drugs affecting the immune response - 13.05.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section Interim Clinical Commissioning Policy: Adalimumab for Children with Severe Refractory Uveitis Reference: (D12X02) (11.99.99.99)
link in drug section NICE TA146: Adalimumab for the treatment of adults with psoriasis (13.05.03)
link in drug section NICE TA187: Crohns disease - infliximab & adalimumab (01.05.03)
link in drug section NICE TA329: Infliximab, adalimumab and golimumab for moderately to severely active ulcerative colitis  (01.05.03)
link in drug section NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis (10.01.03)
link in drug section NICE TA373: Adalimumab for JIA (10.01.03)
link in drug section NICE TA375: Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed (10.01.03)
link in drug section NICE TA375: Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed (10.01.03)
link in drug section NICE TA392: Adalimumab for treating moderate to severe hidradenitis suppurativa.  (13.05.03)
link in drug section NICE TA455: Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA455: Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA455: Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA460: Adalimumab and dexamethasone for treating non-infectious uveitis (11.99.99.99)
link in drug section NICE TA460: Adalimumab and dexamethasone for treating non-infectious uveitis (11.04.01)


 

netFormulary